CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Roche agrees to $1bn deal with Dualitas for bispecific antibody research

PartnershipPositive
AI Analysis

Summary

Roche has agreed to a $1 billion deal with Dualitas for bispecific antibody research, representing a significant partnership in the development of this therapeutic modality.

Importance:7/10
Sentiment:
0.60
M&Apartnershipbispecific_antibodyresearch_collaboration
Related Companies

Read the original article

Published by yahoo_finance on September 18, 2026 9:29 AM

Read Original